Skip Navigation Links
Review of pharma stocks fighting covid
18 Nov 2021 (202 views)  

I carried out a review of the pharma stocks that are involved in the fight against covid. They are the stocks that produce the vaccine (Pfizer, Moderna, Sinopharm, Novavax) and in the treatment (Pfizer, Merck).

The financial figures are set out below. 

Based on the forward PE ratio, the ranking (from the lowest) is Novavax, Sinopharm, Moderna, Pfizer, Merck.

Based on dividend yield, the ranking (from the highest) is Sinopharm, Pfizer, Merck. However, it is possible that the other profitable vaccine producers will also declare dividend.

Based on current to the peak price, the ranking (from the lowest) is Moderna, Sinopharm and Merck. 

Based on total debt to equity, the ranking (from the lowest) is Moderna, Pfizer, Merck, Sinopharm, Novavax.

The vaccine producers are Pfizer, Moderna, Sinopharm and Novavax. 

The treatment producers are Pfizer and Merck.

I have now invested in Sinopharm. I may invest in Pfizer (as they are involved in the vaccine and treatment).

It appears, from this report, that the covid will be around for some time. So, these stocks are likely to do well for the forseeable future.

Note - I am giving a personal opinion. This is not investment advice. Do you own research before you decide to invest.

Tan Kin Lian
 


Review of pharma stocks fighting covid
[Back] [Print]


I carried out a review of the pharma stocks that are involved in the fight against covid. They are the stocks that produce the vaccine (Pfizer, Moderna, Sinopharm, Novavax) and in the treatment (Pfizer, Merck).

The financial figures are set out below. 

Based on the forward PE ratio, the ranking (from the lowest) is Novavax, Sinopharm, Moderna, Pfizer, Merck.

Based on dividend yield, the ranking (from the highest) is Sinopharm, Pfizer, Merck. However, it is possible that the other profitable vaccine producers will also declare dividend.

Based on current to the peak price, the ranking (from the lowest) is Moderna, Sinopharm and Merck. 

Based on total debt to equity, the ranking (from the lowest) is Moderna, Pfizer, Merck, Sinopharm, Novavax.

The vaccine producers are Pfizer, Moderna, Sinopharm and Novavax. 

The treatment producers are Pfizer and Merck.

I have now invested in Sinopharm. I may invest in Pfizer (as they are involved in the vaccine and treatment).

It appears, from this report, that the covid will be around for some time. So, these stocks are likely to do well for the forseeable future.

Note - I am giving a personal opinion. This is not investment advice. Do you own research before you decide to invest.

Tan Kin Lian